Marsha E. Reichman

10.3k total citations · 4 hit papers
65 papers, 7.7k citations indexed

About

Marsha E. Reichman is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marsha E. Reichman has authored 65 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marsha E. Reichman's work include Global Cancer Incidence and Screening (6 papers), RNA and protein synthesis mechanisms (5 papers) and Estrogen and related hormone effects (5 papers). Marsha E. Reichman is often cited by papers focused on Global Cancer Incidence and Screening (6 papers), RNA and protein synthesis mechanisms (5 papers) and Estrogen and related hormone effects (5 papers). Marsha E. Reichman collaborates with scholars based in United States, Canada and Australia. Marsha E. Reichman's co-authors include Sean F. Altekruse, Katherine A. McGlynn, Brenda K. Edwards, Nadia Howlader, Matthew J. Hayat, Mary Southworth, Lynn A. G. Ries, Benjamin F. Hankey, Ellis F. Unger and David J. Graham and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Marsha E. Reichman

65 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

2009 1.4k citations Marsha E. Reichman et al. profile →
Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

2007 807 citations Nadia Howlader, Marsha E. Reichman et al. profile →
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study

2008 611 citations Limin X. Clegg, Marsha E. Reichman et al. Cancer Causes & Control profile →
Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

2014 498 citations David J. Graham, Marsha E. Reichman et al. Circulation profile →

Peers

Marsha E. Reichman

ONCOL

EPIDE

CCM

PRM

Joel M. Kremer United States

Hajime Uno United States

Richard H. Bell United States

Elisa Rossi Italy

Diamantis I. Tsilimigras United States

Lin Zhang China

Marianne Ulcickas Yood United States

Nicholas Syn Singapore

Ciro Gallo Italy

Ewen M. Harrison United Kingdom

Joel M. Kremer United States

Marsha E. Reichman

2.5k ×1.2

ONCOL

1.5k ×0.9

EPIDE

690 ×0.6

CCM

2.0k ×1.8

890 ×1.0

PRM

Citations per year, relative to Marsha E. Reichman Marsha E. Reichman (= 1×) peers Joel M. Kremer

Countries citing papers authored by Marsha E. Reichman

Since Specialization

Citations

This map shows the geographic impact of Marsha E. Reichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marsha E. Reichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marsha E. Reichman more than expected).

Fields of papers citing papers by Marsha E. Reichman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marsha E. Reichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marsha E. Reichman. The network helps show where Marsha E. Reichman may publish in the future.

Co-authorship network of co-authors of Marsha E. Reichman

This figure shows the co-authorship network connecting the top 25 collaborators of Marsha E. Reichman. A scholar is included among the top collaborators of Marsha E. Reichman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marsha E. Reichman. Marsha E. Reichman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graham, David J., Rongmei Zhang, Jiemin Liao, et al.. (2019). Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation. The American Journal of Medicine. 132(5). 596–604.e11. 98 indexed citations

Mott, Katrina, et al.. (2019). Use of Antidiabetic drugs during pregnancy among U.S. women with Livebirth deliveries in the Mini-Sentinel system. BMC Pregnancy and Childbirth. 19(1). 441–441. 5 indexed citations

Taylor, Lockwood G., Steven T. Bird, Leyla Şahin, et al.. (2017). Antiemetic use among pregnant women in the United States: the escalating use of ondansetron. Pharmacoepidemiology and Drug Safety. 26(5). 592–596. 47 indexed citations

Nelson, Jennifer C., Robert Wellman, Onchee Yu, et al.. (2016). A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data. SHILAP Revista de lepidopterología. 4(1). 17–17. 7 indexed citations

Andrade, Susan E., Marsha E. Reichman, Katrina Mott, et al.. (2016). Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration’s Mini-Sentinel program. Archives of Women s Mental Health. 19(6). 969–977. 39 indexed citations

Andrade, Susan E., Sengwee Toh, Monika Houstoun, et al.. (2015). Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program. Maternal and Child Health Journal. 20(4). 895–903. 31 indexed citations

Graham, David J., Marsha E. Reichman, Michael Wernecke, et al.. (2014). Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation. Circulation. 131(2). 157–164. 498 indexed citations breakdown →

Howlader, Nadia, Lynn A. G. Ries, Angela B. Mariotto, et al.. (2010). Improved Estimates of Cancer-Specific Survival Rates From Population-Based Data. JNCI Journal of the National Cancer Institute. 102(20). 1584–1598. 358 indexed citations

Harper, Sam, Nicholas B. King, Stephen C. Meersman, et al.. (2010). Implicit Value Judgments in the Measurement of Health Inequalities. Milbank Quarterly. 88(1). 4–29. 217 indexed citations

10.

Dignam, James J., Lan Huang, Lynn A. G. Ries, et al.. (2009). Estimating breast cancer‐specific and other‐cause mortality in clinical trial and population‐based cancer registry cohorts. Cancer. 115(22). 5272–5283. 42 indexed citations

11.

Anderson, W. French, Sheng Luo, Nilanjan Chatterjee, et al.. (2008). Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Research and Treatment. 113(1). 189–196. 34 indexed citations

12.

Watson, Meg, Mona Saraiya, Faruque Ahmed, et al.. (2008). Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods. Cancer. 113(S10). 2841–2854. 131 indexed citations

13.

Goodman, Marc T., Brenda Y. Hernandez, Stephen M. Hewitt, et al.. (2005). Tissues from population-based cancer registries: a novel approach to increasing research potential. Human Pathology. 36(7). 812–820. 35 indexed citations

14.

Breslow, Rosalind A., Louise Wideroff, Barry I. Graubard, et al.. (1999). Alcohol and Prostate Cancer in the NHANES I Epidemiologic Follow-Up Study. Annals of Epidemiology. 9(4). 254–261. 42 indexed citations

15.

Apter, Dan, et al.. (1998). Possible mechanisms mediating an association between physical activity and breast cancer. Cancer. 83(S3). 621–628. 101 indexed citations

16.

Dorgan, Joanne F., Marsha E. Reichman, Joseph T. Judd, et al.. (1995). The relation of body size to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes & Control. 6(1). 3–8. 43 indexed citations

17.

Dorgan, Joanne F., Marsha E. Reichman, J T Judd, et al.. (1995). Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women.. PubMed. 4(4). 381–6. 89 indexed citations

18.

Wyroba, Elżbieta, et al.. (1994). The Activity of Parafusin Is Distinct from That of Phosphoglucomutase in the Unicellular Eukaryote Paramecium. Biochemical and Biophysical Research Communications. 200(3). 1353–1358. 18 indexed citations

19.

Reichman, Marsha E., J T Judd, Christopher Longcope, et al.. (1993). Effects of Alcohol Consumption on Plasma and Urinary Hormone Concentrations in Premenopausal Women. JNCI Journal of the National Cancer Institute. 85(9). 722–727. 286 indexed citations

20.

Winn, Deborah M., Marsha E. Reichman, & Elaine W. Gunter. (1990). EPIDEMIOLOGIC ISSUES IN THE DESIGN AND USE OF BIOLOGIC SPECIMEN BANKS. Epidemiologic Reviews. 12(1). 56–70. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact